Clinical Trial Update: Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating goserelin 10.8 mg injection for advanced prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Advanced Prostate Cancer | Phase 3 | Status: COMPLETED